FDA OKs four Illumina gene-sequencing devices

|By:, SA News Editor

Illumina (ILMN) has received approval for four "next-generation" gene-sequencing devices that have the potential to make quicker and more accurate diagnoses of cystic fibrosis,

The tests will search for "the largest number of cystic fibrosis gene variations that we've ever cleared a test for," the FDA's Elizabeth Mansfield said.

Two of the tests also have potential to be used to diagnose and treat certain genetically identifiable cancers. (PR)